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As part of the neuronal cytoskeleton, neurofilaments are involved in maintaining cellular
integrity. In the setting of ischemic stroke, the affection of the neurofilament network
is considered to mediate the transition towards long-lasting tissue damage. Although
peripheral levels of distinct neurofilament subunits are shown to correlate with the
clinically observed severity of cerebral ischemia, neurofilaments have so far not been
considered for neuroprotective approaches. Therefore, the present study systematically
addresses ischemia-induced alterations of the neurofilament light (NF-L), medium
(NF-M), and heavy (NF-H) subunits as well as of α-internexin (INA). For this purpose, we
applied a multi-parametric approach including immunofluorescence labeling, western
blotting, qRT-PCR and electron microscopy. Analyses comprised ischemia-affected
tissue from three stroke models of middle cerebral artery occlusion (MCAO), including
approaches of filament-based MCAO in mice, thromboembolic MCAO in rats, and
electrosurgical MCAO in sheep, as well as human autoptic stroke tissue. As indicated by
altered immunosignals, impairment of neurofilament subunits was consistently observed
throughout the applied stroke models and in human tissue. Thereby, altered NF-L
immunoreactivity was also found to reach penumbral areas, while protein analysis
revealed consistent reductions for NF-L and INA in the ischemia-affected neocortex
in mice. At the mRNA level, the ischemic neocortex and striatum exhibited reduced
expressions of NF-L- and NF-H-associated genes, whereas an upregulation for Ina
appeared in the striatum. Further, multiple fluorescence labeling of neurofilament
proteins revealed spheroid and bead-like structural alterations in human and rodent
tissue, correlating with a cellular edema and lost cytoskeletal order at the ultrastructural
level. Thus, the consistent ischemia-induced affection of neurofilament subunits in
animals and human tissue, as well as the involvement of potentially salvageable
tissue qualify neurofilaments as promising targets for neuroprotective strategies. During
ischemia formation, such approaches may focus on the maintenance of neurofilament
integrity, and appear applicable as co-treatment to modern recanalizing strategies.
Keywords: cerebral ischemia, stroke, MCAO, neurofilaments, α-internexin, axonal spheroids
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INTRODUCTION
Ischemic stroke represents one of the leading causes of
death world-wide and is estimated to be the fourth most
important cause of increased disability-adjusted life-years by
2030 (Donnan et al., 2008), causing long-lasting disabilities
and thereby contributing to a high socio-economic burden
(Mozaffarian et al., 2016). Despite enormous efforts in
preclinical and clinical research, stroke therapy is still limited to
intravenous administration of recombinant tissue plasminogen
activator (rtPA) and mechanical thrombectomy to re-establish
cerebral blood flow after an acute vessel occlusion (Hacke
et al., 2008; Berkhemer et al., 2015). Moreover, based on the
narrow therapeutic time window and other restrictions due
to potential complications, only a small percentage of patients
are currently eligible for these treatments (Dirks et al., 2011;
Albers et al., 2018). Therefore, the need for the development of
novel therapeutic approaches is still evident. Considering the
translational roadblock from bench to bedside, i.e., the repeatedly
failed translation of promising experimental approaches into the
clinical setting (O’Collins et al., 2006), a detailed understanding
of pathophysiological changes is mandatory for the development
of novel and supportive treatment options.
Based on a comprehensive perspective of stroke-related tissue
damage as captured by the “neurovascular unit” (NVU) and
the penumbra concept (Astrup et al., 1981; Zlokovic, 2005; del
Zoppo, 2009), experimental research has substantially improved
the understanding of stroke pathophysiology (Dirnagl et al.,
1999; Dirnagl, 2012). However, the underlying mechanism for
the transition from an acute to long-lasting tissue damage is
still ill-defined. In this context, proteins of the neurofilament
network are assumed to play a pivotal role in maintaining
cellular integrity (Yuan et al., 2012). In the setting of stroke,
this concept is supported by two recent studies reporting on
a significant correlation between the cerebrospinal fluid (CSF)
level of neurofilament proteins and the degree of clinical stroke
severity as well as the amount of white matter lesions in humans
(Jonsson et al., 2010; Hjalmarsson et al., 2014).
In general, neurofilaments are elastic and fibrous proteins,
representing essential and mechanically resilient components
of the neuronal cytoskeleton (Wagner et al., 2007). They are
considered as a particularly stationary and metabolically stable
network (Yuan et al., 2009), which is integrated into the
various other elements of the cytoskeleton, such as microtubules
and actin filaments. Thereby, neurofilaments are involved in
maintaining neuronal shape and the regulation of the axonal
caliber (Friede and Samorajski, 1970; Hoffman et al., 1984,
1987). Here, they are shown to impact on conduction velocity
and excitability and to facilitate the slow component of axonal
transport (Griffin and Watson, 1988). The neurofilament protein
of the central nervous system consists of three subunits:
Neurofilament light (NF-L), neurofilament medium (NF-M) and
neurofilament heavy (NF-H), which are named according to
their molecular weights of 67–69 kD, 145-160 kD and 200 kD,
respectively. These subunits are often called the neurofilament
triplet, which is closely associated with α-internexin (INA),
the latter of which is considered as a fourth and functionally
interdependent neurofilament subunit (Yuan et al., 2006,
2012).
Under pathophysiological conditions, these neurofilament
subunits are known to increase or accumulate in some
neurodegenerative diseases. Such accumulations can most
distinctly be found within cell bodies and proximal axons in
patients suffering from amyotrophic lateral sclerosis (Julien
et al., 1995), but high levels of neurofilaments, especially
phosphorylated neurofilaments, have also been described for
Alzheimer’s disease (Cork et al., 1986) and Parkinson’s disease
(Forno et al., 1986). Remarkably, these observations are in line
with experimental data obtained from mice, in which increased
serum and CSF levels of NF-L were found to correspond with
the progression of neurodegenerative diseases (Lu et al., 2015;
Bacioglu et al., 2016a,b). Due to an assumed release from
damaged neurons, a significant increase of NF-L in the CSF was
regularly detectable in patients suffering from cerebral infarction
(Norgren et al., 2003; Hjalmarsson et al., 2014). Further, increased
serum levels of phosphorylated NF-H were found to correlate
with the clinical outcome of stroke patients (Singh et al., 2011)
and with experimentally induced neuronal damage (Shaw et al.,
2005).
Since critical affections of the neurofilament network are
likely to represent a central mechanism during the transition
towards an irreversible neuronal damage after ischemic
stroke, these structures may constitute possible targets for
neuroprotective therapies. Therefore, the present study was
aimed to systematically investigate ischemia-mediated affections
of individual neurofilament proteins. Taking into account
translational aspects, this study comprises different stroke
models of middle cerebral artery occlusion (MCAO) in three
different species, as well as human autoptic stroke tissue.
MATERIALS AND METHODS
Study Design
All animal experiments were performed according to the
European Union Directive 2010/63/EU and the German
guideline for care and use of laboratory animals after approval
by local authorities (Regierungspräsidium Leipzig; reference
numbers TVV 34/11 for rats, TVV 51/14 and TVV 02/17 for
mice, TVV 56/15 for sheep). Reporting of animal experiments
followed the ARRIVE guidelines (Kilkenny et al., 2010).
Adult male C57BL/6 mice with a mean weight of 25 g,
provided by Charles River (Sulzfeld, Germany), underwent
a filament-based approach of permanent right-sided MCAO
(fMCAO). Adult male Wistar rats with a mean weight of
300 g, also provided by Charles River, underwent right-sided
thromboembolic permanent MCAO (eMCAO). Sufficient stroke-
induced affection was confirmed using the Menzies Score
(Menzies et al., 1992), ranging from 0 (no neuronal deficit)
to 4 (spontaneous contralateral circling). Here, mice and rats
had to demonstrate at least a score of 2, serving as pre-
defined study inclusion criterion. Mice and rats were sacrificed
24 h after ischemia induction. In total, the study included six
rats and five mice for immunofluorescence microscopy-based
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analyses, five mice for quantitative analyses using western blot
and qRT-PCR, as well as four mice for electron microscopy. The
analyses also comprised tissue from six male adult sheep, which
underwent surgically induced permanent MCAO (sMCAO) with
a follow-up period of 2 weeks. The sheep tissue was provided
by the Faculty for Veterinary Medicine, University of Leipzig,
Germany.
Further data were obtained from post-mortem brain tissue of
a patient suffering from ischemic stroke provided by J. Kattah
(Department of Neurology, University of Illinois College of
Medicine, Peoria, IL, United States). Autoptic brainstem sections
comprised ischemia-affected areas of the lateral medulla of a
61-year-old male individual who died 3 weeks after onset of
stroke. Further details on the analyzed brain tissue and stroke
characterization are given in Kattah et al. (2017).
Induction of Focal Cerebral Ischemia in
Mice, Rats, and Sheep
In mice, fMCAO was performed according to Longa et al.
(1989), with minor modifications as previously described
(Hawkes et al., 2013). In brief, mice were deeply anesthetized
by intraperitoneal application of etomidate (33 mg/kg body
weight, Hypnomidate, Janssen-Cilag, Neuss, Germany) followed
by insertion of a standardized silicon-coated 6-0 monofilament
(Doccol Corporation, Redlands, CA, United States) into the
internal carotid artery. The filament was carefully pushed forward
to the origin of the right middle cerebral artery until bending was
observed or resistance felt.
In rats, eMCAO was applied according to Zhang et al.
(1997), with slight modifications as described before (Michalski
et al., 2009). In brief, anesthesia was achieved using 2–2.5%
isoflurane (Baxter, Unterschleißheim, Germany) and a vaporizer
(VIP 3000, Matrix, New York, NY, United States) providing a
mixture of 70% N2O/30% O2. A PE-50 catheter with a previously
prepared weight-adapted blood clot was positioned in the distal
section of the internal carotid artery after insertion via the
external carotid artery. Here, the blood clot was injected with
a small bolus of saline followed by careful catheter removal.
During surgery, the body temperature of mice and rats was
controlled and adjusted to 37◦C with a rectal probe and a
thermostatically regulated warming pad (Fine Science Tools,
Heidelberg, Germany).
In sheep, sMCAO was performed as described previously
by Nitzsche et al. (2016). Briefly, sheep were anesthetized by
an intravenous injection of ketamine (4 mg/kg body weight;
Ketamin, Medistar, Holzwicke, Germany), xylazine (0.1 mg/kg
body weight; Xylazin, Ceva Sante Animal GmbH, Düsseldorf,
Germany), and diazepam (0.2 mg/kg body weight; Temmler
Pharma GmbH, Marburg, Germany). During surgery, anesthesia
was maintained by mechanical ventilation with 2% isoflurane
and 40% oxygen (Primus, Dräger AG, Lübeck, Germany).
The left temporal bone was exposed, followed by trepanation
with a 6 mm barrel burr at 10,000 rpm (microspeed uni,
scil animal care company, Viernheim, Germany). Next, the
dura mater was incised and the proximal middle cerebral
artery was occluded by electrosurgical coagulation using
neurosurgical bipolar forceps (ME 411, KLS Martin, Tuttlingen,
Germany). Thereafter, the dura mater was repositioned followed
by suturing of muscles and skin. Finally, the animals were
treated with antibiotics (enrofloxacin, 5% Baytril, Bayer
AG, Leverkusen, Germany) and analgesics (Butorphanol,
Alvegesic 1%; CP-pharm, Burgdorf, Germany) and were
allowed to wake up after surgery. The presence of cerebral
infarctions was confirmed by PET/MR imaging (Werner et al.,
2015).
Tissue Preparation
Mice and rats used for immunofluorescence microscopy were
sacrificed followed by transcardial perfusion with saline and
2.5–4% paraformaldehyde (PFA) in phosphate buffered saline
(PBS). After removal from the skull, the brains were post-fixed
in the same fixative for 24 h, followed by equilibration in
30% phosphate-buffered sucrose. For fluorescence labeling,
the forebrains were serially cut into coronal 30 µm-thick
sections using a freezing microtome (Leica SM 2000R, Leica
Biosystems, Wetzlar, Germany). All rodent brain sections were
then stored at 4◦C in 0.1 M Tris-buffered saline, pH 7.4 (TBS),
containing 0.2% sodium azide. Mice used for western blot and
qRT PCR analyses were sacrificed and perfused with saline
only. After removal from the skull, brains were manually cut
and ischemia-affected areas, being demarked by the ischemia-
associated edema, as well as the respective contralateral regions
were dissected, snap-frozen in liquid nitrogen and stored at
−80◦C.
Sheep were euthanized, brains were removed, and coronal
specimens were obtained. Subsequently, the about 10 mm-thick
equally spaced slices were immersed into 4% buffered PFA
for 14 days. The slices were then equilibrated in 30%
phosphate-buffered sucrose and consecutively cut at 40µm
thickness using a freezing microtome (Microm HM 430, Thermo
Fisher Scientific, Waltham, MA, United States). All specimens
were collected in 0.1 M TBS, pH 7.4, containing 0.2% sodium
azide and stored at 4◦C.
Human tissue was cut into 5 mm slices followed by
formaldehyde fixation and embedding in paraffin. The tissue
was further sectioned and mounted onto microscope slides.
Prior to immunofluorescence labeling, paraffin sections were
deparaffinized in xylene and rehydrated in graded alcohols,
followed by antigen retrieval in 0.1 M citrate buffer, pH 6, for
15 min in a microwave oven at 96◦C.
Immunofluorescence Labeling and
Microscopy
Prior to immunofluorescence labeling, the tissue was thoroughly
rinsed in TBS and incubated in TBS blocking buffer containing
5% normal donkey serum and 0.3% Triton X-100 for 1 h.
Next, primary antibodies (Table 1) were added for overnight
incubation. Sections were washed with TBS followed by
incubation with mixtures of appropriate fluorochromated
secondary immunoreagents (Table 1) in TBS containing 2%
bovine serum albumin for 1 h at room temperature. For
the successive labeling of rabbit-anti-INA and biotinylated
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TABLE 1 | Immunoreagents used for immunohistochemistry.
Immunoreagent Dilution Manufacturer
Primary antibody
Rabbit-anti-neurofilament L 1:200 Synaptic Systems, Göttingen,
Germany
Biotinylated
rabbit-anti-neurofilament L IgG
1:100 Synaptic Systems
Rabbit-anti-α-internexin
(clone EPR1529)
1:500 Abcam, Cambridge,
United Kingdom
Guinea pig-anti-
neurofilament M
1:200 Synaptic Systems
Guinea pig-anti-neurofilament H 1:200 Synaptic Systems
Biotinylated
mouse-anti-neurofilament H
IgG (clone NE14)
1:100 Merck Millipore, Billerica, MA,
United States
Mouse-anti-MAP2 (clone HM-2) 1:500 Sigma, Taufkirchen, Germany
Mouse-anti-HSP70 (clone
C92F3A-5)
1:200 Enzo, Lausen, Switzerland
Guinea pig-anti-NeuN 1:200 Synaptic Systems
Secondary antibody/immunoreagent
Cy2-donkey-anti-rabbit IgG 20 µg/ml
each
Dianova (Hamburg, Germany)
as supplier for Jackson
ImmunoResearch (West Grove,
PA, United States)
Cy3-donkey-anti-rabbit IgG
Cy5-donkey-anti-guinea
pig IgG
AlexaFluor488-donkey-anti
-mouse IgG
Cy2-streptavidin
Cy3-streptavidin
rabbit-anti-NF-L, the remaining free binding sites of secondary
antibodies were blocked with TBS buffered 50% normal rabbit
serum for 4 h, followed by overnight incubation of biotinylated-
rabbit-anti-NF-L and visualization with Cy3-streptavidin for 1 h.
All sections were extensively rinsed with TBS. Animal sections
were mounted onto fluorescence-free microscope slides, dried,
and cover-slipped with Entellan R© in toluene (Merck, Darmstadt,
Germany). Human brain tissue was further treated with Sudan
Black B (Merck) to quench tissue-specific autofluorescence
(Schnell et al., 1999) and cover-slipped with glycerol gelatin
(Sigma, Taufkirchen, Germany). For all the applied experiments,
the omission of primary antibodies resulted in the absence
of any labeling. Images for qualitative and quantitative data
were captured with the Biorevo BZ-9000 microscope (Keyence,
Neu-Isenburg, Germany), whereas high-magnification images
were acquired with a confocal laser-scanning microscope (LSM
510 Meta, Carl Zeiss Microscopy, Göttingen, Germany).
Fluorescence Intensity Measurements
For semi-quantification of NF-L-, NF-M-, NF-H- and
INA-related fluorescence intensity in the model of fMCAO
in mice, regions of interest (ROIs) were defined in the
ischemia-affected areas of the neocortex and the striatum
and equally mirrored to the contralateral hemisphere using the
BZ-II-Viewer Software (Keyence). In detail, three consecutive
forebrain slices per animal and per area with a distance of
300 µm apart were selected with the middle slice demonstrating
the most pronounced ischemic lesion. For neocortical areas,
8 ROIs with a field dimension of 181 µm × 136 µm and a
distance of 72 µm between their boundaries were distributed
within the neocortical layers II-IV of the somatosensory cortex
and parietal cortex. ROIs were defined from medial to lateral,
extending from the unaffected to the most affected tissue as
indicated by NF-L labeling. In the striatum, 12 ROIs with a field
dimension of 362 µm × 272 µm and a distance of 144 µm
between their boundaries were evenly distributed within the area
of the striatum. Here, 4 ROIs each were placed in the central,
transitional, and peripheral area of increased NF-L-related
immunoreactivity. All ROIs were mirrored to the contralateral,
non-affected hemisphere and served as controls. In summary, 24
cortical ROIs and 36 striatal ROIs were captured per hemisphere,
immunolabeling and animal (n = 5). Micrographs were captured
using a 12-bit CCD camera (Keyence) at a constant exposure
time for each immunolabeling and area (striatum and neocortex).
Prior to intensity measurements, a minimum threshold for each
immunolabeling was set in order to minimize the error caused by
unspecific background intensities. Thresholds had been adjusted
individually for each immunolabeling until the background
intensity could be nearly excluded without affecting or deleting
specific signals. The fluorescence intensity of each ROI was
measured using ImageJ software (National Institutes of Health,
Bethesda, MD, United States) by analyzing the integrated density,
which reflects the mean gray value per analyzed area.
Western Blot and Quantitative Real-Time
PCR (qRT-PCR)
For western blot analyses each brain sample was homogenized
and lysed by ultrasonification in 60 mM Tris–HCl, pH 6.8,
containing 2% sodium dodecyl sulfate (SDS) and 10% sucrose,
supplemented with a protease inhibitor cocktail (Cell Signaling,
Leiden, The Netherlands) on ice, followed by centrifugation at
13,000 rpm and 4◦C for 10 min. Protein concentrations were
then measured using the BCA kit (Thermo Fisher, Waltham,
MA, United States). Next, proteins were denaturated in sample
buffer (250 mM Tris–HCl, pH 6.8, containing 4% SDS, 10%
glycerol, and 2% β-mercaptoethanol) at 95◦C for 5 min. Proteins
were separated using a 12.5% SDS-PAGE and transferred to
nitrocellulose membranes (Th.Geyer, Renningen, Germany).
Then, membranes were blocked with 5% dry milk in TBS (50 mM
Tris–HCl, 150 mM NaCl, pH 7.5) for 30 min and incubated
with primary antibodies (Table 2) at 4◦C overnight. After three
rinsing steps with washing buffer (6 g/l Tris, 8.8 g/l NaCl,
3 ml/l Tween 20), membranes were incubated with horseradish
peroxidase-conjugated secondary antibodies (Table 2) for 1 h
and developed with the ECL kit (Thermo Fisher). After image
acquisition, membranes were stripped with stripping buffer
(15 g/l glycine, 1 g/l SDS, 10 ml/l Tween 20, pH 2.2) and reused to
detect β-actin as housekeeping protein for reference. The relative
protein concentration of NF-L and INA was calculated from the
respective β-actin immunosignal.
For qRT-PCR, the total RNA was extracted according
to the peqGOLD RNAPureTM manual (VWR, Darmstadt,
Germany) and RNA concentration was quantified by using
a NanoDrop spectrophotometer (VWR). From each sample
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TABLE 2 | Antibodies used for western blot.
Immunoreagent Dilution Manufacturer
Primary antibody
Mouse-anti-neurofilament L
(clone DA2)
1:1000 Thermo Fisher, Waltham, MA,
United States
Rabbit-anti-neurofilament L 1:2000 Synaptic Systems, Göttingen,
Germany
Rabbit-anti-α-internexin 1:5000 Abcam, Cambridge,
United Kingdom
Mouse-anti-β-actin 1:2000 Cell Signaling, Danvers, MA,
United States
Secondary antibody
HRP-horse-anti-mouse IgG 1:10000 Vector Laboratories, Burlingame,
CA, United States
HRP-goat-anti-rabbit IgG 1:10000 Vector Laboratories
500 ng RNA was reversely transcribed into cDNA using the
ProtoScript M-MuLV First Strand cDNA Synthesis Kit (New
England Biolabs Inc., Ipswich, MA, United States) and a
mixture of oligo(dT) and random primers according to the
manufacturer’s instructions. For qRT-PCR measurements, the
levels of mRNA transcripts were quantified by duplication using
the Rotor-Gene Q Instrument and the conformed Rotor-Gene
SYBR Green PCR Kit (Qiagen, Hilden, Germany) according
to the manufacturer’s instructions. For this purpose, the
correlated gene-specific primer pairs (Table 3) were previously
designed with the online tool Primer3web version 4.1.01
and produced by biomers.net GmbH (Ulm, Germany). The
mRNA levels were measured using the relative standard curve
analysis, in which each sample was tested in triplicate and
Actb was used as endogenous control gene (Saksi et al.,
2011).
Electron Microscopy
For clear-cut identification of ischemia-affected areas, fluorescein
isothiocyanate (FITC)-conjugated albumin was intravenously
applied 1 h prior to sacrifice to demark areas with impaired
blood-brain barrier (BBB) integrity. Animals were sacrificed and
transcardially perfused with saline and a fixative containing
4% PFA and 0.5% glutaraldehyde. Then, brains were removed
from the skull and post-fixed in the same fixative for 24 h.
Next, the brains were coronally cut into serial sections with
a thickness of 50 µm using a vibratome (Leica Microsystems,
Wetzlar, Germany) in cooled PBS. Ischemia-affected areas with
1http://primer3.ut.ee/
impaired BBB were identified using peroxidase-conjugated anti-
FITC IgG (1:2000 = 0.5 µg/ml; Dianova, Hamburg, Germany)
and diaminobenzidine as previously described (Krueger et al.,
2017). Sections were then further stained with 0.5% osmium
tetroxide (EMS, Hatfield, PA, United States) for 30 min, followed
by subsequent rinsing in PBS and dehydration with 30, 50, and
70% ethanol (J. T. Baker, Deventer, The Netherlands). After
application of 1% uranyl acetate (Serva) in 70% ethanol for
1 h, the sections were further dehydrated using 80%, 90%, 96%,
100% ethanol and propylene oxide (Sigma-Aldrich, Steinheim,
Germany). The sections were incubated in Durcupan (Sigma-
Aldrich) and embedded between coated microscope slides and
cover slips prior to the polymerization process at 56◦C for
48 h. Areas showing BBB breakdown were identified by light
microscopy, marked, and transferred onto blocks of resin for
a second polymerization step. After trimming of the blocks,
ultra-thin sections with a thickness of 55 nm were cut using
an ultra-microtome (Leica Microsystems). Finally, the sections
were transferred on formvar-coated grids and stained with lead
citrate for 6 min. Ultrastructural analysis was performed using
a Zeiss SIGMA electron microscope (Zeiss NTS, Oberkochen,
Germany).
Statistical Analyses and Image
Processing
The acquired data was processed with Graph Pad Prism 5.01v
(GraphPad Software Inc., La Jolla, CA, United States). Since
ischemia-affected areas were compared with corresponding
contralateral control areas, the Wilcoxon test was applied to
check for statistical significance. In general, data are given as
means ± standard error of mean (SEM) and a value of p < 0.05
was considered statistically significant. Figure panels were
generated with Microsoft PowerPoint (version 2015; Microsoft
Corp., Redmond, WA, United States). If necessary, brightness
and contrast of images were slightly adjusted without creating or
deleting signals.
RESULTS
Consistently Altered Immunoreactivities
of Neurofilament Proteins Throughout
the Applied Animal Models of MCAO
To address the expression patterns of NF-L, NF-M, NF-H,
and INA in ischemia-affected tissue, we applied double
immunofluorescence labeling for NF-L and NF-H as well as
TABLE 3 | Primer used for PCR.
Target gene Encoded protein Forward primer Reverse primer
Nefl NF-L TCAAGGCTAAGACCCTGGAG AGGCCATCTTGACATTGAGG
Ina INA AAATGGCCCTTGACATTGAG TGGGAGGGAGCAAATAACTG
Nefm NF-M AAACTCCTAGAGGGGGAAGA GCCTCGACTTTGGTCTTCTG
Nefh NF-H ACTCTCAGAGGCAGCCAAAG AGCAGGTCCTGGTACTCTCG
Actb β-actin CATCCGTAAAGACCTCTATGCCAAC ATGGAGCCACCGATCCACA
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NF-M and INA in the mouse model of fMCAO and the rat
model of eMCAO at 24 h after ischemia induction. Here,
severe alterations of the respective expression patterns were
observed in neocortical as well as striatal areas, when compared
to the contralateral, unaffected hemisphere (Figure 1). While
the immunoreactivities for INA, NF-M, and NF-H appeared
to be decreased in ischemia-affected regions, an increased
fluorescence intensity was observed for NF-L. As the most
prominent differences were observed for INA and NF-L,
immunofluorescence labeling of these proteins was combined
with labeling of NF-M or NF-H. Thus, analyses of the infarct
border consistently revealed decreased fluorescence intensities
for INA and NF-M, while the immunoreactivity of NF-L
was found to be increased in the ischemic areas throughout
the models of fMCAO (Figure 2) and eMCAO (Figure 3).
In contrast, rather inconsistent changes of the immunosignal
were observed for NF-H. However, especially in the model
of eMCAO, structural deformations of fibers and aberrant
cellular processes became apparent by NF-H labeling in border
zones of the ischemic lesion (Figure 3). These observations
were confirmed in sheep after sMCAO, with most pronounced
changes observed for NF-L and INA (Supplementary Figure
S1), while NF-H immunoreactivity remained unaltered (data not
shown).
Increased NF-L Immunoreactivity
Extends to the Ischemic Penumbra
Further, we tried to determine whether or not the described
alterations include areas of potentially salvageable tissue
FIGURE 1 | Affection of neurofilament subunits in mice 24 h after
experimental stroke induction. Representative overview showing double
immunofluorescence labeling of NF-L and NF-H (A) as well as of INA and
NF-M (B) 24 h after fMCAO. Ischemia-affected areas are demarcated by an
increase of NF-L immunoreactivity, while the immunosignals for INA, NF-M,
and NF-H are found to be decreased. Dashed lines outline the border of
increased NF-L immunoreactivity within ischemia-affected areas (i). Scale
bars: 1 mm.
FIGURE 2 | Opposite alterations of neurofilament subunits at the infarct
border after fMCAO in mice. Triple immunofluorescence labeling of NF-L, INA,
and NF-M (A) as well as of NF-L, INA, and NF-H (B) is shown at the ischemic
border zone and in respective contralateral control areas in the neocortex of
mice 24 h after ischemia induction. Notably, NF-L appears to be upregulated
in the ischemia-affected area, whereas the same area is characterized by
decreased immunoreactivities of INA, NF-M, and slightly of NF-H. Dashed
lines outline the border of increased NF-L immunoreactivity within
ischemia-affected areas (i). Scale bars: (A) 100 µm; (B) 200 µm.
according to the concept of an infarct core and a shell-like
surrounding penumbra (Astrup et al., 1981). Therefore, we
applied double immunofluorescence labeling of NF-L and
microtubule-associated-protein-2 (MAP2), since the attenuation
of MAP2 labeling is described to include penumbral areas of
cerebral ischemia (Dawson and Hallenbeck, 1996; Kharlamov
et al., 2009; Popp et al., 2009; Härtig et al., 2016). Further,
according to Sharp et al. (2000) the outer layers of the
ischemia-affected penumbra can be identified by an increased
immunosignal of heatshock protein 70 (HSP70), since the
expression of HSP70 is considered to represent an endogenous
protective mechanism that occurs in neurons of the penumbra
but not of the ischemic core (Kato et al., 1995; Weinstein et al.,
2004). Therefore, triple immunofluorescence labeling of NF-L
in combination with HSP70 and neuronal nuclei (NeuN) was
applied.
Of note, ischemia-related loss of MAP2 labeling
co-localized with a clear-cut enhancement of the NF-L-related
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FIGURE 3 | Opposite alterations of neurofilament subunits at the infarct
border after eMCAO in rats. Triple immunofluorescence labeling of NF-L, INA,
and NF-M (A) as well as of NF-L, INA, and NF-H (B) is shown at the ischemic
border zone and in respective contralateral control areas in the model of
eMCAO in rats 24 h after ischemia induction. Notably, in the ischemia-affected
area NF-L appears to be upregulated, whereas the same area is characterized
by decreased immunoreactivities of INA and NF-M. While the reduction of
NF-H related immunolabeling appears to be faint, structural deformations of
fibers and cellular processes became visible (B). Dashed lines outline the
border of increased NF-L immunoreactivity within ischemia-affected areas (i).
Scale bars: (A) 100 µm; (B) 200 µm.
immunoreactivity (Figure 4A). Further, the increased
immunoreactivity of NF-L also comprised areas of HSP70-
positive neurons (Figure 4B), thus representing penumbral
areas.
Semi-Quantitative Analyses of
Neurofilament-Related Immunoreactivity
To quantify the described ischemia-related alterations, the
individual fluorescence intensity for each of the investigated
neurofilament components was measured in the model of
fMCAO and compared with control areas (Figure 5). Thereby,
the fluorescence intensity of NF-L was found to significantly
increase in ischemic cortical areas compared to the contralateral
hemisphere (ROI 4–8: 171.9–180.3%) as well as from ROI 2 to
4, representing the border zone towards the ischemia-affected
tissue. This increase was similarly confirmed in the ischemic
FIGURE 4 | Co-labeling of NF-L with ischemia-sensitive neuronal markers
Double immunofluorescence labeling illustrates the alternate affection of NF-L
and MAP2-related immunoreactivity. The border of the ischemic area (i) is
characterized by a clear-cut loss of MAP2-related immunolabeling (dashed
line), whereas the immunoreactivity of NF-L is increased (A). The ischemic
penumbra is demarked by upregulation of HSP70 in NeuN-positive neurons
(white arrows), which co-localizes with upregulated NF-L immunoreactivity,
demonstrating ischemia-derived affection of NF-L in potentially salvageable
tissue (B). The corresponding contralateral area serves as control. Scale bars:
(A) 100 µm; (B) 75 µm.
striatum from peripheral to central areas as well as in
direct comparison to the contralateral regions (central: 396.8%;
transitional: 224.4%).
In contrast to NF-L and in a rather opposite expression
pattern, the fluorescence intensity of INA (Figure 5) was
shown to be significantly reduced when compared to the
contralateral hemisphere (ROI 3–8: 47.4–29.1%) and explicitly
from ROI 2 to 4, representing the border zone towards the
ischemia-affected tissue. This decrease of INA immunoreactivity
was further evident from peripheral to central areas in the
ischemia-affected striatum (transitional: 53.8%; central: 42.7%).
In addition, a similar but less pronounced decrease was
observed for NF-M (Figure 5). Here, a significant decrease
became evident at the border zone of the ischemic tissue
(ROI 2–4) and in ROI 4 (48.9%) and 5 (59%) compared
to the contralateral hemisphere. In striatal areas, a relative
decrease of NF-M fluorescence intensity was observed, but
failed to reach statistical significance. In line with the less
pronounced alterations of NF-H-related fluorescence intensity,
its semi-quantitative analysis did not reveal significant differences
(Figure 5).
Western Blot Reveals Reduced NF-L and
INA Protein Levels in Ischemia-Affected
Tissue
To rule out that the observed increase of NF-L-related
immunoreactivity is caused by better accessibility of the
antibody in the ischemia-affected and structurally impaired
tissue, we further explored relative protein levels of NF-L and
additionally INA using western blot analysis. Here, the protein
amount of NF-L was found to be significantly reduced in
ischemic neocortical areas when compared to the contralateral
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FIGURE 5 | Semi-quantification of NF-L, INA, NF-M, and NF-H immunofluorescence intensity in the model of fMCAO. Coronal mouse brain sections labeled with
NF-L (red) and NF-H (green) illustrate the predefined ROIs in the cortex (A), as well as the peripheral (P), transitional (T), and central (C) areas of the striatum
(B). Semi-quantification reveals a significant increase of NF-L immunoreactivity, as well as a significant decrease of INA immunoreactivity in the ischemic tissue of the
neocortex (A) and striatum (B). NF-M immunoreactivity is significantly decreased in the ischemic neocortex, while NF-H immunoreactivity is not significantly altered
(A). NF-M and NF-H show a trend towards decreased immunoreactivities in the ischemic striatum (B). Data are given as mean values; error bars indicate SEM.
∗p < 0.05; n = 5.
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hemisphere, whereas in the striatum, this trend failed to reach
statistical significance (Figures 6A,B). However, western blot
analysis revealed an increase of detectable bands with associated
lower molecular weight in ischemic regions (Figure 6C),
which are known to relate to NF-L degradation products
(Posmantur et al., 1994). Thereby, a strong and significant
increase of bands ranging from 40–65 kDa was observed in
neocortical and striatal areas when compared to the contralateral
regions (Figure 6C). Since the decreased levels of the 68 kDa
NF-L protein appear to be contradictory to the increased
immunofluorescence intensity observed in histological sections,
additional western blot analyses were performed using another
established monoclonal mouse-anti-NF-L antibody (DA2) with
proven specificity in ischemia-affected tissue (Schroeder et al.,
2003). In line with the aforementioned findings (Figure 6A),
the NF-L (DA2)-detected protein amount in the ischemic
neocortex and striatum was also reduced in comparison to
the contralateral hemisphere (Supplementary Figures S2a,b),
but failed to reach statistical significance. Importantly, the
NF-L degradation products smaller than 65 kDa were not
detected by the monoclonal mouse-anti-NF-L antibody (DA2)
in the western blot (Supplementary Figure S2b), which
corresponds with decreased fluorescence intensities in the
ischemia-affected tissue, thereby co-localizing with the increased
immunosignal of the rabbit NF-L antibody (Supplementary
Figure S2c).
In conformity with the data obtained from
immunofluorescence microscopy, protein levels of INA appeared
to be reduced with the most pronounced ischemia-related
affections in neocortical areas (Figure 6D). Taken together,
western blot analyses revealed an ischemia-induced relative
reduction of NF-L and INA protein levels, which predominantly
affected neocortical regions.
Reduced Nefl and Nefh mRNA Levels in
Combination With an Upregulation of Ina
in Ischemic Areas
In addition to analyses at the protein level, we further investigated
the mRNA levels of Nefl (NF-L), Ina (INA), Nefm (NF-M), and
Nefh (NF-H) using qRT-PCR (Figures 6E,F). The mRNA level of
Nefl was significantly decreased in ischemia-affected neocortical
areas, whereas in the striatum the differences did not reach
statistical significance. In contrast, the mRNA level of Ina is
shown to be significantly upregulated in the striatum, but not in
the neocortex. Further analyses addressing the mRNA level did
not reveal significant inter-hemispheric differences for Nefm, but
a significant downregulation for Nefh in the ischemic neocortex.
FIGURE 6 | Western blot and qRT-PCR analyses of fMCAO tissue. Western blot analyses reveal a significantly lower protein level of NF-L in the ischemic neocortex
and a slightly lower level in the ischemic striatum (A,B). The ischemia-affected striatum and neocortex exhibit increased bands of lower molecular weight
(∼40–65 kDa) compared to control areas (B,C). Western blot analysis reveals a trend towards decreased INA expression in the ischemic neocortex compared to
control areas (D). qRT-PCR shows significantly decreased mRNA levels of Nefl and Nefh in the cortex (E), while the mRNA level of Ina is significantly increased in the
striatum (F). Actb served as endogenous control gene (E,F). Bars and squares indicate mean values; error bars indicate SEM. ∗p < 0.05; n = 5.
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Comparable Alterations of
Neurofilaments in Human Stroke Tissue
To address the question of whether the described alterations
of NF-L, NF-M, NF-H, and INA in the applied stroke models
also hold true for the human pathophysiology, we performed
respective immunofluorescence labeling on human autoptic
stroke tissue. Importantly, human stroke tissue exhibited a
comparable enhancement of NF-L-related immunoreactivity
as previously described in the animal models (Figure 7A).
Higher magnification reveals a clear-cut border of the increased
NF-L immunosignal (Figure 7B, dashed line) which correlates
with the previously characterized ischemic border zone (dashed
line, Figure 7A) of the analyzed brain stem tissue (Kattah
et al., 2017). In addition and in line with the animal
models, decreased immunoreactivities were observed for NF-M
(Figure 7B) and INA (Figure 7C) in ischemia-affected areas.
In line with the animal models, the decrease of NF-H-related
fluorescence intensity appeared much less pronounced compared
FIGURE 7 | Opposite affections of neurofilament subunits and morphological alterations in human post-mortem stroke tissue. Overview of human autoptic brain
stem tissue with histopathologically verified infarct (i) delineated by a dashed line (A). Higher magnification reveals alterations comparable to the findings in animal
MCAO models with most profound ischemia-derived affection of NF-L and INA. NF-L shows an increased immunoreactivity within the ischemic area (B), while NF-M
(B) and INA (C) appear to be decreased. A representative image illustrates characteristic morphological bead-like neuronal alterations, which can be visualized using
each of the applied neuronal markers at high magnification (D). Dashed lines indicate ischemia-affected areas. Rectangle in (A) illustrates the area captured in (B) at
higher magnification. Abbreviations: ICP, inferior cerebellar peduncle; NXII, hypoglossal nerve; ML, medial lemniscus; IO, inferior olive; PT, pyramidal tract. Scale bars:
(A) 2 mm; (B) 200 µm; (C) 750 µm; (D) 100 µm.
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to NF-M and INA (not shown). Notably, NF-L, NF-M, and
NF-H labeling regularly revealed characteristic morphological
alterations, captured by higher magnification (Figure 7D). Here,
spheroid axonal structures, as signs of axonal damage (Kattah
et al., 2017), were regularly found in ischemia-affected tissue,
especially in affected white matter fiber tracts (Figure 7D).
Characteristic Morphological Alterations
in Stroke Models and Human Autoptic
Stroke Tissue
After detecting morphological alterations by visualization
of neurofilament proteins in human ischemia-affected
tissue (Figure 8A), higher magnification revealed similar
structures indicative of axonal damage, such as spheroid
and bead-like structures in all the animal models applied
(Figures 8B–F). In line with the observations in human stroke
tissue (Figures 7D, 8A), spheroid and bead-like structures are
visualized by NF-L, NF-M, and NF-H labeling (Figure 8B).
Further, high magnification revealed irregular, bulged, and
swollen appearing neuronal processes (Figure 8C) as well
as bead-like NF-L-positive structures which appeared to be
discontinuous to adjacent neuronal structures (Figure 8D).
Partly, the described bead-like formations appeared to be
connected to neuronal processes, such as apical dendrites
(Figure 8E), whereas in other cases, the integrity of the respective
processes was found to be lost (Figure 8F).
Structurally Impaired Axons and
Dendrites Revealed by Electron
Microscopy
To further analyze these alterations at an ultrastructural level,
electron microscopy regularly revealed bead-like vacuolations
of affected myelinated axons (Figure 8G). Moreover, captured
dendrites often appeared to be swollen and less electron-dense,
indicative of the ischemia-associated cellular edema (Figure 8H).
In these cases, the regular alignment of cytoskeletal elements,
such as microtubules and neurofilaments, is shown to be
impaired (Figure 8H, inset). Importantly, the described
alterations were not only observed throughout the cortical areas
(Figures 8G,H), but were also present in the ischemia-affected
striatum (Figure 8I). In general, the ischemia-associated cellular
edema was found to not only affect neurons, but also surrounding
glial processes (Figures 8G–I).
DISCUSSION
Although modern recanalizing therapies have proven beneficial
in clinical trials (Hacke et al., 2008; Berkhemer et al., 2015),
they are still limited to only about one fourth of acutely affected
patients (Dirks et al., 2011). Furthermore, the translational
roadblock from bench to bedside is illustrated by the remarkable
number of more than 1,000 experimental treatment strategies,
all of which failed successful translation into the clinical setting
(O’Collins et al., 2006). Therefore, a detailed understanding of
stroke pathophysiology is essential for successful development of
FIGURE 8 | Morphological alterations of neuronal processes due to ischemia
demonstrated by immunofluorescence and electron microscopy.
Morphological alterations as demarcated by NF-L, NF-M, and NF-H labeling
observed in human stroke tissue (A) are detectable throughout the applied
animal models of MCAO (B–F). NF-L immunolabeling reveals swollen and
morphologically altered axons (C) and bulb-like vacuolization of NF-L-positive
structures (D). Of note, bead-like deformations (arrow heads) are visible in
continuity with neuronal processes (E) as well as apparently discontinuous to
respective axons or dendrites (arrow heads) (F). Electron microscopy images
obtained from the neocortex in the model of fMCAO illustrate severe
alterations of the neuronal cytoskeleton resulting in vacuolization of axons
(arrows) (G) comparable to the bead-like structures captured by
immunofluorescence microscopy (D–F). Further, non-myelinated dendrites
often appear less electron dense and swollen (transparently highlighted in
yellow) indicative of a cellular edema, resulting in an impaired cytoskeletal
order (insets) with lost alignment of microtubules and neurofilaments (H).
Swollen and structurally altered cellular processes with an impaired
cytoskeleton are also observed in the ischemia-affected striatum (I). Generally,
a cellular edema is also detectable in surrounding ischemia affected glial cells
(asterisks). Scale bars: (A–F) 25 µm; (G–I) 2 µm.
neuroprotective therapies targeting the transition from acute to
irreversible and long-lasting tissue damage. So far, neurofilament
proteins proved to be sensitive markers of brain damage
(Martínez-Morillo et al., 2015) and were further shown to
correlate with the clinical outcome of stroke patients (Singh et al.,
2011; Traenka et al., 2015). As ischemia-derived alterations of
these neuronal elements might represent a central mechanism
during the transition process towards long-lasting tissue damage
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(Härtig et al., 2016), the present study was aimed to systematically
characterize ischemia-associated affections of the neurofilament
network.
In this study, stroke-related alterations of the four critical
subunits NF-L, NF-M, NF-H, and INA were for the first
time analyzed by using a multi-parametric approach including
immunofluorescence labeling, western blot, qRT-PCR as well as
electron microscopy. Considering translational aspects, this study
was designed according to the STAIR recommendations and thus
includes three different animal models and species as well as
human autoptic stroke tissue in order to enhance reproducibility
and validity (Fisher et al., 2009).
Notably, in all MCAO models, immunoreactivities for INA,
NF-M, and partly for NF-H were consistently found to be
decreased, while NF-L immunofluorescence intensity related
to the applied polyclonal rabbit-anti NF-L antibody appears
clearly increased. Among the investigated proteins, especially
NF-L and INA exhibited the most striking and significant
ischemia-derived affections, showing a sharp border of an
increased NF-L immunoreactivity co-localized with strikingly
decreased immunoreactivities for INA.
Importantly, the described alterations of NF-L protein
expression are not confined to areas of neuronal cell death
in the infarct core (Astrup et al., 1981). Instead, we were
able to demonstrate that the detectable increase of NF-L
immunoreactivity not only delineates the ischemic border zone
as outlined by the loss of MAP2 immunolabeling (Dawson and
Hallenbeck, 1996; Härtig et al., 2016), but further co-localizes
with areas exhibiting HSP70-positive neurons (Figure 4). In
fact, this is of particular interest, as the area of neuronal
HSP70 expression was previously described to exceed the area
of ischemia-mediated neuronal cell death (Sharp et al., 2000;
Weinstein et al., 2004). In these areas, HSP70 expressing neurons
are presumed to survive the ischemic insult (Abe et al., 1992; Li
et al., 1993; Klettner, 2004). Thus, the described alterations of the
neuronal cytoskeleton comprise areas of the ischemic penumbra
(Kato et al., 1995), which represents potentially salvageable tissue
(Sharp et al., 2000), thereby distinguishing neurofilaments as
potential targets for future neuroprotective strategies.
However, the ischemia-derived increase of NF-L
immunoreactivity is rather contradictory to previous
reports, which demonstrate reduced immunoreactivities for
neurofilaments in histological sections and western blot analysis
after traumatic brain injury and stroke (Ogata et al., 1989;
Inuzuka et al., 1990; Posmantur et al., 1994; Schroeder et al.,
2003). For this reason, western blot analysis of NF-L and INA
was added. Importantly, this method revealed reduced levels
for both the 68 kDa NF-L protein and INA (Figures 6A,D).
However, western blot analysis revealed that the polyclonal
rabbit-anti-NF-L antibody used for immunohistochemistry not
only detects the 68 kDa NF-L protein, but also degradation
products smaller than 68 kDa (Figures 6B,C) as described by
Posmantur et al. (1994). This significant increase of detectable
NF-L degradation products in the ischemic tissue might well
explain the enhanced NF-L immunofluorescence intensity in
histological sections with the applied polyclonal rabbit-anti-NF-L
antibody (Figure 5). Of note, decreased protein levels of NF-L
were further confirmed using a monoclonal mouse-anti-NF-L
(DA2) antibody (Supplementary Figure S2), which does not
recognize NF-L degradation products and therefore provides
decreased immunofluorescence intensities on histological
sections. This decrease precisely co-localizes with increased
NF-L immunosignals related to the polyclonal rabbit-anti-NF-L
antibody (Supplementary Figure S2c).
Although the general use of the monoclonal mouse-anti-NF-L
antibody may seem more appropriate as it shows decreased
immunoreactivities in histological sections in line with decreased
protein levels in the western blot, its use for stroke research
may be impaired on widely applied unfixed or shortly fixed
snap-frozen tissue. Here, secondary antibodies would also detect
intrinsic unfixed IgG, thereby spoiling the intended analysis.
Therefore, the applied polyclonal rabbit-anti-NF-L antibody
proved to be a valuable tool to consistently detect alterations
of NF-L throughout the applied animal models and human
stroke tissue, and further reliably allows the detection of the
ischemia-affected areas. These findings qualify the applied NF-L
antibody as a highly ischemia-sensitive marker, whose sensitivity
compared to NF-M and NF-H can be explained by its higher
susceptibility to proteolytic degradation (Petzold, 2005), as
well as the stoichiometry of the subunit composition of 5:3:1
for NF-L:NF-M:NF-H (Lobsiger and Cleveland, 2009), which
renders NF-L immunolabeling proportionally more susceptible
to altered protein levels.
In order to systematically characterize cytoskeletal alterations
in the analyzed tissue, efforts were made to supplement data
on the respective mRNA levels. The reduced mRNA levels for
Nefl and Nefh, might reflect the incapacity of affected cells to
maintain their functioning cytoskeleton (Figure 6E) and are in
line with previous reports demonstrating a reduced NF-H protein
expression 3 days after ischemia-induction in a model of MCAO
(Inuzuka et al., 1990). Although a robust reduction of NF-H
immunofluorescence intensity was not observed in the present
study, these changes are likely to be preceded by the reduced Nefh
mRNA level (Figures 6E,F) since the half-lives of neurofilament
proteins appear to be much longer compared to the respective
mRNA (Barry et al., 2007; Maier et al., 2009). On the other hand,
the protein level of INA was reduced in striatal regions, whereas
the Ina mRNA level appeared to be increased (Figures 6D–F).
However, as mRNA levels usually exhibit a poor correlation with
the respective protein levels (Maier et al., 2009) the time course
of the described alterations further needs to be addressed by
longitudinal studies including shorter and longer time points
after ischemia induction.
Qualitatively, by applying immunofluorescence labeling of
NF-L, NF-M, and NF-H bead-like and spheroid deformations
of neuronal processes were observed (Figures 7D, 8B) showing
axonal spheroids as a sign of axonal damage (Kattah et al.,
2017). Such bead-like deformations have been reported to occur
as axonal “blebbing” in cell culture experiments as soon as
15 min after the insult and are shown to lead to extensive axonal
degeneration (Castillo and Babson, 1998). Accordingly, swelling
of neurites was observed in the setting of focal cerebral ischemia
(Uzdensky et al., 2016). Of note, in the present study, these
bulb-like structures often appeared to be disconnected from each
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other as exemplified by NF-L labeling (Figures 8D,F). Similar
observations were previously interpreted as a stage of bulb-like
axonal disconnections (Dewar and Dawson, 1997). In the present
study, we were able to identify morphological correlates for the
observed spheroid-shaped alterations at an ultrastructural level.
In detail, bead-like deformations were regularly observed for
axons and signs of an intracellular edema became apparent in
unmyelinated dendrites, thereby resulting in a loss of the regular
alignment of neurofilaments and microtubules (Figure 8H).
Further structural affections of axons and dendrites, as well as the
surrounding glia were identified in cortical and striatal areas and
substantiate the alterations visualized by immunofluorescence
microscopy.
Although the present study design is rather descriptive, we
here provided a systematic, translational-oriented approach to
investigate alterations of neurofilaments due to focal cerebral
ischemia applying a variety of animal models and human
stroke tissue. Nevertheless, as the presented quantitative data
are based on a single time point (24 h after ischemia
induction), future studies are needed to analyze cytoskeletal
damage in ischemic areas and respective border zones in a
longitudinal fashion, from the very early period after ischemia
onset over days and weeks. The given time point, however,
was chosen to allow detection of cellular alterations in a
time window that appears realistic for future pharmacological
intervention. This time window is further known to correlate
with an increased BBB permeability that harbors the risk
of hemorrhagic transformation and cerebral edema formation
(Huang et al., 1999; Durukan et al., 2009; Pillai et al., 2009),
both representing clinically relevant complications associated
with poor functional outcome (Battey et al., 2014; Stokum et al.,
2016).
In summary, the robust evidence for critical quantitative
and structural alterations of the neurofilament network in
ischemia-affected areas, including potentially salvageable tissue,
distinguishes neurofilament subunits as possible targets for
upcoming therapeutic approaches. Ideally, a pharmacological
modulation which optimizes cellular integrity by stabilizing the
neurofilament network appears conceivable for both scenarios:
First, as a novel neuroprotective strategy in a time window of at
least 24 h, and second, as potential co-treatment in addition to
modern techniques of vascular recanalization.
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